This compound is a pharmaceutical intermediate featuring a cyclobutane-diamine core substituted with a methyl group and a pyrrolopyrimidine heterocyclic ring. It is primarily used as a building block in the synthesis of active pharmaceutical ingredients.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 1622980-99-7
Despropanesulfonyl Abrocitinib
Pharmaceutical intermediate for abrocitinib
2-acetyl-2-azabicyclo[2.2.1]hept-5-en-3-one
Abacavir impurity intermediate
Bis(2-(7-methoxynaphthalen-1-yl)ethyl)aminehydrochloride
Agomelatine impurity reference standard
2,4-Dichlorothieno[3,2-d]pyrimidine
Pharmaceutical intermediate
2-Acetamido-2-(4-octylphenethyl)propane-1,3-diyl diacetate
pharmaceutical intermediate
(1s,3s)-N-hydroxy-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutanecarboxamide
research compound for kinase inhibition
N-(cis-3-(Methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-1-propanesulfonamide
Janus kinase inhibitor
1-N-methyl-1-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)cyclobutane-1,3-diamine
DSZFXAFWOBUIFN-UHFFFAOYSA-N
CN(C1CC(C1)N)C2=NC=NC3=C2C=CN3
—